Market Overview

Bio-Rad Acquires Cell Sorting System From Propel Labs

Related BIO
Benzinga's Daily Biotech Pulse: Insmed Presents Data, Pfenex Pulls Back On Offering, Oncolytics Listing
Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products today announced that they have acquired a new cell sorting system from Propel Labs. Under the terms of agreement, Bio-Rad has acquired an automated, easy-to-use benchtop sorting flow cytometer. The instrument will be offered by Bio-Rad as the S3(TM) Cell Sorter. First shipments are anticipated in January 2013. Other terms of the agreement were not disclosed.

Posted-In: News Asset Sales


Related Articles (BIO)

View Comments and Join the Discussion!